TRNS: financial statements from SEC — TradeAlmanac

TRNS

Transcat, Inc.: financial statements

Company reports as filed with the U.S. Securities and Exchange Commission.

AnnualQuarterly

Income statement

Metric	Mar 31, 2026	Mar 31, 2025
Revenue	332m	278m
Cost of revenue	224m	189m
Gross profit	108m	89m
Selling, general and administrative	52m	38m
Operating expenses	95m	72m
Operating income	13m	18m
Pre-tax income	8m	18m
Income tax	3m	4m
Net income	5m	15m
Earnings per share	0.58	1.58
Earnings per share, diluted	0.57	1.57
Weighted average shares	9m	9m
Weighted average shares, diluted	9m	9m

Balance sheet

Metric	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024
Cash and equivalents	5m	3m	5m	2m	2m	5m	24m	23m
Short-term investments	—

Cash flow

Metric	Mar 31, 2026	Mar 31, 2025
Operating cash flow	35m	39m
Depreciation and amortisation	26m	19m
Share-based compensation	8m	3m
Capital expenditure	15m	13m
Investing cash flow	−98m	−84m
Share buybacks	469,000

Amounts in USD unless stated otherwise. Sources: Nasdaq Trader, Yahoo Finance, U.S. Securities and Exchange Commission (EDGAR)